dyslipidemia

(redirected from Dyslipidemias)
Also found in: Dictionary.

dyslipidemia

 [dis-lip″id-e´me-ah]
abnormality in, or abnormal amounts of, lipids and lipoproteins in the blood; see hyperlipidemia and hypolipidemia.

dyslipidemia

/dys·lip·id·e·mia/ (-lip″id-e´me-ah) abnormality in, or abnormal amounts of, lipids and lipoproteins in the blood.

dyslipidemia

(dĭs-lĭp′ĭ-dē′mē-ə)
n.
An abnormal concentration of lipids or lipoproteins in the blood.

dys·lip′i·de′mic (-mĭk) adj.

dyslipidemia

[dislip′id·ē′mē·ə]
Etymology: Gk, dys, difficult + lipid + Gk, haima, blood
abnormality in, or abnormal amounts of, lipids and lipoproteins in the blood. See also hyperlipidemia, hypolipoproteinemia.

dyslipidemia

Metabolic disease Any defect in lipoprotein metabolism–eg ↑ cholesterol, ↑ TGs, combined hyperlipidemia, and ↓ HDL-C; dyslipidemias may be 1º–ie nosologies a sui generis or 2º to other medical conditions–eg, DM or hypothyroidism

dys·lip·i·de·mi·a

(dis-lip'i-dē'mē-ă)
Any biochemical disorder characterized by one or more abnormal levels of blood lipids.
References in periodicals archive ?
Frequencies of various dyslipidemias in different grades of NAFLD were compared using chi-square test.
Dyslipidemia and tobacco smoking synergistically increase serum manganese
We would like to determine the frequency of dyslipidemias in non-diabetic and normotensive obese subjects to in this study.
In this study, patients with hypertension were more prone to dyslipidemias compared with those who were normotensives.
Dyslipidemias are estimated to be frequent events in patients using HAART; nevertheless, up to the present time, few studies have investigated the prevalence of these abnormalities in Brazil.
All adults and adolescents with CKD should be evaluated for dyslipidemias.
Guidelines 4 and 5, on treatment of dyslipidemias in adults and adolescents, call for lifestyle changes (such as improving diet, increasing physical activity, and reducing weight).
Complete lipid profiling should follow overnight fasting whenever possible; remediable, secondary causes of dyslipidemia should be identified if possible.
Guidelines 2 and 3 address evaluation of stage 5 disease patients, and state that complete lipid profiling should follow overnight fasting whenever possible and that remediable, secondary causes for dyslipidemias should be identified when possible.
com/research/x64jlc/treatment_algorith) has announced the addition of the "Treatment Algorithms: Dyslipidemia - Statin Monotherapies Dominate the Market but Uncontrolled Lipid Levels Remain an Issue" report to their offering.
Amongst the various dyslipidemias in diabetic patients the most common finding is hypertriglyceridemia, followed by decreased levels of high density lipoprotein cholesterol (HDL-C), raised low density lipoprotein cholesterol (LDL-C) and increased total cholesterol levels4,5.